- Home
- Publications
- Publication Search
- Publication Details
Title
Role of Arsenic Trioxide in Acute Promyelocytic Leukemia
Authors
Keywords
-
Journal
CURRENT TREATMENT OPTIONS IN ONCOLOGY
Volume 14, Issue 2, Pages 170-184
Publisher
Springer Nature
Online
2013-01-15
DOI
10.1007/s11864-012-0223-3
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- All-trans-retinoic acid, idarubicin, and IV arsenic trioxide as initial therapy in acute promyelocytic leukemia (APML4)
- (2012) H. J. Iland et al. BLOOD
- Oral administration of arsenic trioxide in the treatment of acute promyelocytic leukaemia and accelerated phase chronic myeloid leukaemia: an Australian single-centre study
- (2012) F. Firkin INTERNAL MEDICINE JOURNAL
- Oral arsenic trioxide-based maintenance regimens for first complete remission of acute promyelocytic leukemia: a 10-year follow-up study
- (2011) W.-Y. Au et al. BLOOD
- Early death rate in acute promyelocytic leukemia remains high despite all-trans retinoic acid
- (2011) J. H. Park et al. BLOOD
- The pathogenesis and management of the coagulopathy of acute promyelocytic leukaemia
- (2011) Karen A. Breen et al. BRITISH JOURNAL OF HAEMATOLOGY
- Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
- (2011) H. Iland et al. HAEMATOLOGICA
- Phase II Study of Single-Agent Arsenic Trioxide for the Front-Line Therapy of Acute Promyelocytic Leukemia
- (2011) Ardeshir Ghavamzadeh et al. JOURNAL OF CLINICAL ONCOLOGY
- Oral arsenic trioxide for relapsed acute promyelocytic leukemia in pediatric patients
- (2011) Wing Y. Au et al. PEDIATRIC BLOOD & CANCER
- Risk-adapted treatment of acute promyelocytic leukemia based on all-trans retinoic acid and anthracycline with addition of cytarabine in consolidation therapy for high-risk patients: further improvements in treatment outcome
- (2010) M. A. Sanz et al. BLOOD
- BCOR as a novel fusion partner of retinoic acid receptor alpha in a t(X;17)(p11;q12) variant of acute promyelocytic leukemia
- (2010) Y. Yamamoto et al. BLOOD
- Front-line treatment of acute promyelocytic leukemia with AIDA induction followed by risk-adapted consolidation for adults younger than 61 years: results of the AIDA-2000 trial of the GIMEMA Group
- (2010) F. Lo-Coco et al. BLOOD
- Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710
- (2010) B. L. Powell et al. BLOOD
- Single Cycle of Arsenic Trioxide–Based Consolidation Chemotherapy Spares Anthracycline Exposure in the Primary Management of Acute Promyelocytic Leukemia
- (2010) Steven D. Gore et al. JOURNAL OF CLINICAL ONCOLOGY
- Single-Agent Arsenic Trioxide in the Treatment of Newly Diagnosed Acute Promyelocytic Leukemia: Long-Term Follow-Up Data
- (2010) Vikram Mathews et al. JOURNAL OF CLINICAL ONCOLOGY
- Prognostic significance of FLT3 internal tandem duplication and tyrosine kinase domain mutations in acute promyelocytic leukemia: A systematic review
- (2010) Amer Beitinjaneh et al. LEUKEMIA RESEARCH
- Use of All-trans Retinoic Acid in Combination with Arsenic Trioxide for Remission Induction in Patients with Newly Diagnosed Acute Promyelocytic Leukemia and for Consolidation/Maintenance in CR Patients
- (2009) Chong-Wen Dai et al. ACTA HAEMATOLOGICA
- Two cases of monocular visual loss during oral arsenic trioxide therapy of acute promyelocytic leukemia
- (2009) Wing-Yan Au et al. AMERICAN JOURNAL OF HEMATOLOGY
- Comparison of Clinical Outcomes of Patients with Relapsed Acute Promyelocytic Leukemia Induced with Arsenic Trioxide and Consolidated with Either an Autologous Stem Cell Transplant or an Arsenic Trioxide–Based Regimen
- (2009) Rajasekar Thirugnanam et al. BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION
- Long-term efficacy and safety of all-trans retinoic acid/arsenic trioxide-based therapy in newly diagnosed acute promyelocytic leukemia
- (2009) J. Hu et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Determinants of cerebrospinal fluid arsenic concentration in patients with acute promyelocytic leukemia on oral arsenic trioxide therapy
- (2008) W.-Y. Au et al. BLOOD
- Molecular analysis of t(15;17) genomic breakpoints in secondary acute promyelocytic leukemia arising after treatment of multiple sclerosis
- (2008) S. K. Hasan et al. BLOOD
- Management of acute promyelocytic leukemia: recommendations from an expert panel on behalf of the European LeukemiaNet
- (2008) M. A. Sanz et al. BLOOD
- Acute promyelocytic leukemia: from highly fatal to highly curable
- (2008) Z.-Y. Wang et al. BLOOD
- The seventh pathogenic fusion gene FIP1L1-RARA was isolated from a t(4;17)-positive acute promyelocytic leukemia
- (2008) T. Kondo et al. HAEMATOLOGICA
- Effective Treatment of Acute Promyelocytic Leukemia With All-Trans-Retinoic Acid, Arsenic Trioxide, and Gemtuzumab Ozogamicin
- (2008) Farhad Ravandi et al. JOURNAL OF CLINICAL ONCOLOGY
- A novel arsenical has antitumor activity toward As2O3-resistant and MRP1/ABCC1-overexpressing cell lines
- (2008) Z Diaz et al. LEUKEMIA
- Eradication of acute promyelocytic leukemia-initiating cells through PML-RARA degradation
- (2008) Rihab Nasr et al. NATURE MEDICINE
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started